SynAct Pharma AB (STO: SYNACT)
8.83
+1.11 (14.30%)
Aug 30, 2024, 5:29 PM CET
SynAct Pharma AB Revenue
SynAct Pharma AB had revenue of 2.89M SEK in the quarter ending June 30, 2024, a decrease of -52.06%. This brings the company's revenue in the last twelve months to 14.92M, down -13.91% year-over-year. In the year 2023, SynAct Pharma AB had annual revenue of 19.87M with 19.49% growth.
Revenue (ttm)
14.92M
Revenue Growth
-13.91%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
364.65M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 19.87M | 3.24M | 19.49% |
Dec 31, 2022 | 16.63M | -688.74K | -3.98% |
Dec 31, 2021 | 17.32M | 2.42M | 16.27% |
Dec 31, 2020 | 14.90M | 8.09M | 118.80% |
Dec 31, 2019 | 6.81M | -2.55M | -27.26% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
ABB Ltd | 342.58B |
Investor AB (publ) | 240.73B |
Investor AB (publ) | 240.73B |
Atlas Copco AB | 177.12B |
Atlas Copco AB | 177.12B |
AB Volvo (publ) | 552.20B |
AB Volvo (publ) | 552.20B |